PMID- 30876484
OWN - NLM
STAT- MEDLINE
DCOM- 20190708
LR  - 20210825
IS  - 1756-0500 (Electronic)
IS  - 1756-0500 (Linking)
VI  - 12
IP  - 1
DP  - 2019 Mar 15
TI  - Type 2 diabetes mellitus prevalence and risk scores in treated PLWHIV: a 
      cross-sectional preliminary study.
PG  - 145
LID - 10.1186/s13104-019-4183-6 [doi]
LID - 145
AB  - OBJECTIVE: This was a preliminary study whose objective was to estimate the 
      prevalence and risk of developing type 2 diabetes mellitus (T2DM) among people 
      living with HIV (PLWHIV) based on diabetes risk assessment scores. RESULTS: The 
      study was composed of 234 PLWHIV with median age (interquartile range, IQR) of 44 
      (36, 52) and a female preponderance of 66%. The median risk scores (IQR) for 
      developing T2DM was 5 (2, 9). Based on the risk scores, 5% of PLWHIV were at high 
      risk for developing T2DM close to 3.4% actual prevalence in the study population. 
      This study demonstrated the importance of using a cheap and fast method for 
      identifying high risk individuals for developing T2DM.
FAU - Masenga, Sepiso K
AU  - Masenga SK
AD  - School of Medicine and Health Sciences, Mulungushi University, Livingstone 
      Campus, Livingstone, Zambia. smasenga@mu.ac.zm.
AD  - Research Section, Pathology Laboratory Department, Livingstone Central Hospital, 
      Akapelwa Street, Livingstone, Zambia. smasenga@mu.ac.zm.
AD  - Department of Biomedical Sciences, School of Health Sciences, University of 
      Zambia, Lusaka, Zambia. smasenga@mu.ac.zm.
FAU - Toloka, Paul
AU  - Toloka P
AD  - Research Section, Pathology Laboratory Department, Livingstone Central Hospital, 
      Akapelwa Street, Livingstone, Zambia.
FAU - Chiyenu, Kaseya
AU  - Chiyenu K
AD  - Internal Medicine, Livingstone Central Hospital, Akapelwa Street, Livingstone, 
      Zambia.
FAU - Imasiku, Ilubala
AU  - Imasiku I
AD  - Chikankata College of Biomedical Sciences, Private Bag Sector 2, Mazabuka, 
      Zambia.
FAU - Mutengo, Hope
AU  - Mutengo H
AD  - Internal Medicine, Livingstone Central Hospital, Akapelwa Street, Livingstone, 
      Zambia.
FAU - Ulungu, Oscar Ngongo
AU  - Ulungu ON
AD  - Internal Medicine, Livingstone Central Hospital, Akapelwa Street, Livingstone, 
      Zambia.
FAU - Mallesu, Zangi
AU  - Mallesu Z
AD  - Research Section, Pathology Laboratory Department, Livingstone Central Hospital, 
      Akapelwa Street, Livingstone, Zambia.
FAU - Mulenga, Eunice
AU  - Mulenga E
AD  - Research Section, Pathology Laboratory Department, Livingstone Central Hospital, 
      Akapelwa Street, Livingstone, Zambia.
FAU - Mutukwa, Macwani
AU  - Mutukwa M
AD  - Research Section, Pathology Laboratory Department, Livingstone Central Hospital, 
      Akapelwa Street, Livingstone, Zambia.
FAU - Kamvuma, Kingsley
AU  - Kamvuma K
AD  - School of Medicine and Health Sciences, Mulungushi University, Livingstone 
      Campus, Livingstone, Zambia.
FAU - Hamooya, Benson M
AU  - Hamooya BM
AD  - School of Medicine and Health Sciences, Mulungushi University, Livingstone 
      Campus, Livingstone, Zambia.
AD  - Research Section, Pathology Laboratory Department, Livingstone Central Hospital, 
      Akapelwa Street, Livingstone, Zambia.
AD  - School of Public Health, University of Zambia, Lusaka, Zambia.
LA  - eng
GR  - D43 TW009744/TW/FIC NIH HHS/United States
PT  - Journal Article
DEP - 20190315
PL  - England
TA  - BMC Res Notes
JT  - BMC research notes
JID - 101462768
RN  - 0 (Anti-Retroviral Agents)
SB  - IM
MH  - Adolescent
MH  - Adult
MH  - Aged
MH  - Aged, 80 and over
MH  - Anti-Retroviral Agents/therapeutic use
MH  - Comorbidity
MH  - Cross-Sectional Studies
MH  - Diabetes Mellitus, Type 2/diagnosis/*epidemiology
MH  - Female
MH  - HIV Infections/drug therapy/*epidemiology/virology
MH  - HIV-1/drug effects/physiology
MH  - Humans
MH  - Male
MH  - Middle Aged
MH  - Prevalence
MH  - Risk Assessment/*methods/*statistics & numerical data
MH  - Risk Factors
MH  - Young Adult
PMC - PMC6420761
OTO - NOTNLM
OT  - Combination antiretroviral therapy
OT  - Diabetes mellitus
OT  - Diabetes risk scores
COIS- The authors declare that they have no competing interests.
EDAT- 2019/03/17 06:00
MHDA- 2019/07/10 06:00
PMCR- 2019/03/15
CRDT- 2019/03/17 06:00
PHST- 2019/01/15 00:00 [received]
PHST- 2019/03/11 00:00 [accepted]
PHST- 2019/03/17 06:00 [entrez]
PHST- 2019/03/17 06:00 [pubmed]
PHST- 2019/07/10 06:00 [medline]
PHST- 2019/03/15 00:00 [pmc-release]
AID - 10.1186/s13104-019-4183-6 [pii]
AID - 4183 [pii]
AID - 10.1186/s13104-019-4183-6 [doi]
PST - epublish
SO  - BMC Res Notes. 2019 Mar 15;12(1):145. doi: 10.1186/s13104-019-4183-6.